Today Zealous intends to sell its subsidiary to pay off legacy debt

Today Zealous, Inc. (OTC Bulletin Board: ZLUS) announced that it is considering selling its stake in Zealous Interactive in order to monetize the valued asset and reduce its legacy debt. Company CFO Gary R. Gottlieb said, "We are in detailed talks with a major creditor and other parties to monetize the web, media and marketing assets owned by Zealous Interactive, a wholly owned subsidiary of Zealous, Inc." Gottlieb went on to say, "The Company cannot guarantee any transaction will occur and there is no assurance that a deal can be completed. We will continue to work smart and hard for the best interest of our investors and creditors."

Zealous Interactive currently owns a social network and web portal. The social network and web portal's member rolls are growing exponentially and are starting to show ad revenue. "All metrics of the sites are progressing tremendously. Within the past month since our beta 1 launch the sites have jumped to a rating within the top 100,000 sites in the US, according to Alexa," according to Gottlieb.

"The number one goal for the company in 2010 is to work towards paying off its debts and settling issues which stem from the 2008 financial crisis which lead to the closing of Zealous Holdings," said Chairman and CEO Milton "Todd" Ault, III. He went onto say, "The company must address the outstanding issues and move forward; therefore by monetizing (Zealous) Interactive, it could possibly help solve a mountain of issues for creditors and shareholders alike." The Company expects to update investors in the first week of January 2010 according to Company officials.

Source:

Zealous, Inc.

Posted in:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.